GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests if patients can stop steroids for good
Disease control CompletedThis study aimed to find the best way to keep a rare autoimmune disease called granulomatosis with polyangiitis (GPA) in remission. It compared whether patients could safely stop taking the steroid prednisone entirely or if they needed to stay on a very low daily dose to prevent …
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 02, 2026 00:42 UTC
-
Smart dosing vs. scheduled shots: a fight to keep a serious autoimmune disease at bay
Disease control CompletedThis study tested two different long-term treatment plans for patients with a serious autoimmune disease called ANCA-associated vasculitis, who were already in remission. The goal was to see which plan was better at preventing the disease from flaring up again. One plan gave ritu…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cheaper copycat drugs put to the test for rare autoimmune disease
Disease control CompletedThis study compared newer, more affordable 'biosimilar' versions of the drug rituximab to the original version in patients with two rare autoimmune diseases (GPA and MPA). Researchers followed 201 Canadian patients for two years to see if the biosimilars worked as well and were a…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Alcoholism drug repurposed to fight pain and fatigue in rare autoimmune diseases
Symptom relief CompletedThis study tested whether a very low dose of an existing drug, naltrexone, could improve daily life for people with vasculitis, a group of rare autoimmune diseases that cause blood vessel inflammation. Sixty patients whose disease was stable but who still struggled with poor phys…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Scientists probe blood cells for clues to tame rare disease
Knowledge-focused CompletedThis study aimed to understand how a specific type of white blood cell, called a neutrophil, behaves in people with granulomatosis with polyangiitis (GPA), a rare autoimmune disease. Researchers studied blood samples from 93 patients to see if changes in these cells could serve a…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC